Cardlytics, Inc.
DE ˙ DB ˙ US14161W1053
0,45 € ↓ -0,04 (-8,23%)
2026-06-05
DEL PRIS
SecurityDE:CYX / Cardlytics, Inc.
InstitutionWorldly Partners Management, Llc
Latest Disclosed Ownership1,157,989 shares
Latest Disclosed Value $ 1,215,888
Worldly Partners Management, Llc ownership in CYX / Cardlytics, Inc.

On May 12, 2026 - Worldly Partners Management, Llc filed a 13F-HR form disclosing ownership of 1,157,989 shares of Cardlytics, Inc. (DE:CYX) valued at $857,607 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,157,989 shares of Cardlytics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $516,463 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 1,216 -8.72 1.0266
2026-02-13 2025-12-31 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 1,332 -52.68 0.9930
2025-11-13 2025-09-30 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 2,814 47.74 1.6803
2025-08-14 2025-06-30 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 1,905 -9.63 1.0443
2025-05-12 2025-03-31 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 2,108 -50.95 1.1930
2025-02-14 2024-12-31 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 4,296 15.95 2.2477
2024-11-14 2024-09-30 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 3,706 -61.03 1.7607
2024-08-14 2024-06-30 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 9,507 -43.34 5.1019
2024-05-15 2024-03-31 13F CARDLYTICS COM 14161W105 1,157,989 0 0.00 16,779 57.33 7.9067
2024-02-14 2023-12-31 13F CARDLYTICS COM 14161W105 1,157,989 161,108 16.16 10,665 -35.16 5.9195
2023-11-14 2023-09-30 13F CARDLYTICS COM 14161W105 996,881 18,592 1.90 16,449 166.06 10.4981
2023-08-14 2023-06-30 13F CARDLYTICS COM 14161W105 978,289 0 0.00 6,183 86.15 3.5398
2023-05-15 2023-03-31 13F CARDLYTICS COM 14161W105 978,289 0 0.00 3,321 -41.26 2.0962
2023-02-14 2022-12-31 13F CARDLYTICS COM 14161W105 978,289 978,289 5,655 4.3969
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.